Literature DB >> 20147481

Composite measures in psoriatic arthritis: GRAPPA 2008.

Dafna D Gladman1, Robert Landewé, Neil J McHugh, Oliver Fitzgerald, Diamant Thaci, Laura Coates, Philip J Mease, Abrar A Qureshi, Gerald G Krueger, Christopher T Ritchlin, Arthur F Kavanaugh, Amit Garg.   

Abstract

At the 2008 annual meeting of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) in Leeds, UK, members discussed the value and current status of composite measures for the assessment of psoriatic arthritis (PsA). In plenary presentations, examples of composite measures developed for rheumatoid arthritis (RA) and ankylosing spondylitis (AS) were reviewed, followed by a presentation of the assessment of disease activity in systemic lupus erythematosus. Three recently devised composite methods of assessing activity or response in PsA also were presented. Considerable discussion followed in breakout groups, and members agreed that a new composite measure specifically for PsA is necessary. The composite measure should include components that encompass the spectrum of psoriatic disease, i.e., in addition to assessment of peripheral joints, it should include assessment of sacroiliitis, spondylitis, enthesitis, and dactylitis, as well as skin and nail disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147481     DOI: 10.3899/jrheum.090956

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Spondyloarthritides: evolving therapies.

Authors:  Andrew Barr; Andrew Keat
Journal:  Arthritis Res Ther       Date:  2010-12-17       Impact factor: 5.156

2.  Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.

Authors:  Eliza K Pontifex; Danielle M Gerlag; Martina Gogarty; Marjolein Vinkenoog; Adrian Gibbs; Ilse Burgman; Ursula Fearon; Barry Bresnihan; Paul Peter Tak; Robin G Gibney; Douglas J Veale; Oliver FitzGerald
Journal:  Arthritis Res Ther       Date:  2011-01-27       Impact factor: 5.156

3.  A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Authors:  Gabrielle H Kingsley; Anna Kowalczyk; Helen Taylor; Fowzia Ibrahim; Jonathan C Packham; Neil J McHugh; Diarmuid M Mulherin; George D Kitas; Kuntal Chakravarty; Brian D M Tom; Aidan G O'Keeffe; Peter J Maddison; David L Scott
Journal:  Rheumatology (Oxford)       Date:  2012-02-17       Impact factor: 7.580

4.  Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.

Authors:  Daniel E Furst; Melody Tran; Emma Sullivan; James Pike; James Piercy; Vivian Herrera; Jacqueline B Palmer
Journal:  Clin Rheumatol       Date:  2017-02-25       Impact factor: 2.980

5.  Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis.

Authors:  Claudio Carneiro; Mario Chaves; Gustavo Verardino; Ana Paula Frade; Pedro Guimaraes Coscarelli; Washington Alves Bianchi; Marcia Ramos-E-Silva; Sueli Carneiro
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.